Literature DB >> 24893151

Association of varicella zoster virus with giant cell arteritis.

Don Gilden1.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 24893151      PMCID: PMC4063377          DOI: 10.1089/mab.2014.0020

Source DB:  PubMed          Journal:  Monoclon Antib Immunodiagn Immunother        ISSN: 2167-9436


× No keyword cloud information.
  14 in total

1.  Two patients with unusual forms of varicella-zoster virus vasculopathy.

Authors:  Donald H Gilden; Howard L Lipton; James S Wolf; William Akenbrandt; John E Smith; Ravi Mahalingam; Bagher Forghani
Journal:  N Engl J Med       Date:  2002-11-07       Impact factor: 91.245

2.  Varicella zoster virus in the temporal artery of a patient with giant cell arteritis.

Authors:  Maria A Nagel; Nelly Khmeleva; Philip J Boyer; Alexander Choe; Robert Bert; Don Gilden
Journal:  J Neurol Sci       Date:  2013-10-02       Impact factor: 3.181

3.  VZV ischemic optic neuropathy and subclinical temporal artery infection without rash.

Authors:  Maria A Nagel; Andrew N Russman; Howard Feit; Igor Traktinskiy; Nelly Khmeleva; D Scott Schmid; Barry Skarf; Don Gilden
Journal:  Neurology       Date:  2012-12-19       Impact factor: 9.910

4.  Varicella zoster virus ischemic optic neuropathy and subclinical temporal artery involvement.

Authors:  Richard Salazar; Andrew N Russman; Maria A Nagel; Randall J Cohrs; Ravi Mahalingam; D Scott Schmid; Bette K Kleinschmidt-DeMasters; Eve M VanEgmond; Don Gilden
Journal:  Arch Neurol       Date:  2011-04

5.  Varicella-zoster virus expression in the cerebral arteries of diabetic subjects.

Authors:  Maria A Nagel; Igor Traktinskiy; Alexander Choe; April Rempel; Don Gilden
Journal:  Arch Neurol       Date:  2012-01

6.  Varicella zoster virus (VZV) in cerebral arteries of subjects at high risk for VZV reactivation.

Authors:  Maria A Nagel; Nelly Khmeleva; Alexander Choe; Jose Gutierrez; Don Gilden
Journal:  J Neurol Sci       Date:  2014-02-08       Impact factor: 3.181

7.  Search for varicella zoster virus and herpes simplex virus-1 in normal human cerebral arteries.

Authors:  Maria A Nagel; Alexander Choe; Nelly Khmeleva; Lindsey Overton; April Rempel; Ann Wyborny; Igor Traktinskiy; Don Gilden
Journal:  J Neurovirol       Date:  2013-03-01       Impact factor: 2.643

Review 8.  Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment.

Authors:  Don Gilden; Randall J Cohrs; Ravi Mahalingam; Maria A Nagel
Journal:  Lancet Neurol       Date:  2009-08       Impact factor: 44.182

9.  VZV multifocal vasculopathy with ischemic optic neuropathy, acute retinal necrosis and temporal artery infection in the absence of zoster rash.

Authors:  Marc Mathias; Maria A Nagel; Nelly Khmeleva; Philip J Boyer; Alexander Choe; Vikram D Durairaj; Jeffrey L Bennett; Naresh Mandava; Don Gilden
Journal:  J Neurol Sci       Date:  2013-01-11       Impact factor: 3.181

10.  Multifocal VZV vasculopathy with temporal artery infection mimics giant cell arteritis.

Authors:  Maria A Nagel; Jeffrey L Bennett; Nelly Khmeleva; Alexander Choe; April Rempel; Philip J Boyer; Don Gilden
Journal:  Neurology       Date:  2013-05-01       Impact factor: 9.910

View more
  4 in total

Review 1.  Pathogenesis of varicelloviruses in primates.

Authors:  Werner J D Ouwendijk; Georges M G M Verjans
Journal:  J Pathol       Date:  2015-01       Impact factor: 7.996

2.  Blinded search for varicella zoster virus in giant cell arteritis (GCA)-positive and GCA-negative temporal arteries.

Authors:  Don Gilden; Teresa White; Nelly Khmeleva; Bradley J Katz; Maria A Nagel
Journal:  J Neurol Sci       Date:  2016-03-19       Impact factor: 3.181

Review 3.  Varicella Zoster Virus in Giant Cell Arteritis: A Review of Current Medical Literature.

Authors:  Rochella A Ostrowski; Sheela Metgud; Rodney Tehrani; Walter M Jay
Journal:  Neuroophthalmology       Date:  2019-07-02

4.  Risk of Stroke and Myocardial Infarction After Herpes Zoster in Older Adults in a US Community Population.

Authors:  Barbara P Yawn; Peter C Wollan; Maria A Nagel; Don Gilden
Journal:  Mayo Clin Proc       Date:  2015-12-15       Impact factor: 7.616

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.